Please login to the form below

Not currently logged in
Email:
Password:

Theranos

This page shows the latest Theranos news and features for those working in and with pharma, biotech and healthcare.

Evolving at home

Evolving at home

The same is true for business behaviour. Theranos failed because the environment selected against the company’s shady behaviour.

Latest news

  • Genetic testing: nothing to write home about? Genetic testing: nothing to write home about?

    dark days of Theranos).

  • Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval

    DIGITAL HEALTH. The inside story of Theranos’ health tech fraud. Published today is the book by Wall Street Journal reporter John Carreyou, Bad Blood: Secrets and Lies in a Silicon Valley ... Startup.  It tells the story of Theranos and its founder

  • Theranos and its CEO settle 'massive fraud' charges Theranos and its CEO settle 'massive fraud' charges

    During this time Silicon Valley-based Theranos, which wanted to revolutionise blood testing, raised more than $700 million from investors. ... Investors were also falsely told by Theranos that the US army used its blood analyser on the battlefield in

  • 2018 by Darwin 2018 by Darwin

    That’s what we learned from Theranos. Darwin, Dawkins and many of my other scientific heroes have been circumspect about the predictive power of evolutionary theory, and rightly so.

  • Acting at random Acting at random

    Looking from the outside, this seems to be Elizabeth Holme's problem at Theranos. ... Great technological and commercial capabilities but something went wrong in the part of Theranos's routineome that expresses the genes for regulatory capabilities.

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics